FAKTOR-OPTIONSSCHEIN - ORION B | Delayed Börse Stuttgart 12:46:43 2024-06-26 EDT | ||
| 7 EUR | +4.01% |
|
| Current month | -28.50% | ||
| 1 month | -31.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 7 | +4.01% |
| 24-06-25 | 6.73 | -0.74% |
| 24-06-24 | 6.78 | -7.25% |
| 24-06-21 | 7.31 | -11.29% |
| 24-06-20 | 8.24 | -3.85% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 12:46 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Morgan Stanley |
| WKN | MG4NA5 |
| ISIN | DE000MG4NA55 |
| Date issued | 2024-05-22 |
| Strike | 47.53 € |
| Maturity | Unlimited |
| Parity | 1.12 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.31 € |
|---|---|
| Lowest since issue | 6.73 € |
| Spread | 0.18 € |
| Spread % | 2.52% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
39.61
EUR
Average target price
38.2
EUR
Spread / Average Target
-3.56%
- Stock Market
- Certificates
- Certificat
